鶹ý

Feature Channels: Alzheimer's and Dementia

Filters close
Go to Advanced Search
Released: 2-Apr-2025 7:30 AM EDT
Pioneering Tests Could Improve the Assessment of Dementia in Ageing Africans
University of the Witwatersrand, Johannesburg

Researchers have introduced improved cognitive tests to assess dementia in older Africans, part of the HAALSI-HCAP study in rural South Africa. These tools, tailored for local contexts, enhance global ageing research and could inform a national survey. With dementia rates rising, findings will aid prevention and policy.

Released: 31-Mar-2025 7:15 PM EDT
باحثو مايو كلينك يدرسون أسباب الخَرَف سريع التقدم
Mayo Clinic

يواجه أغلب مرضى داء الزهايمر والخَرَف المرتبط بداء الزهايمر الظهور والتقدم التدريجين للأعراض الإدراكية، مما يسبب التدهور على مدى سنوات أو عقود. إلا أنه في مجموعة فرعية صغيرة من المرضى تبدأ الأعراض سريعًا، مؤديةً إلى الإصابة بالخَرَف في غضون سنة واحدة والعجز الكامل خلال سنتين من بداية ظهور الأعراض. وتطمح دراسة جديدة تُجرى في مايو كلينك إلى تحديد سبب إصابة مرضى داء الزهايمر والخَرَف المرتبط بداء الزهايمر بهذا الخَرَف سريع التقدم.

Released: 31-Mar-2025 7:15 PM EDT
Pesquisadores da Mayo Clinic estudam as causas da demência rapidamente progressiva
Mayo Clinic

A maioria dos pacientes com doença de Alzheimer (DA) e demências relacionadas à doença de Alzheimer (DRDA) experimenta o início gradual e a progressão dos sintomas cognitivos, levando-os ao declínio ao longo dos anos ou das décadas. No entanto, em um pequeno subconjunto de pacientes, os sintomas começam rapidamente, levando à demência dentro de um ano e à incapacidade total dentro de dois anos após o início dos sintomas. Um novo estudo na Mayo Clinic tem como objetivo determinar por que pacientes com a doença de Alzheimer e DRDA desenvolvem essa demência rapidamente progressiva (DRP).

Released: 31-Mar-2025 7:15 PM EDT
Investigadores de Mayo Clinic estudian las causas de la demencia rápidamente progresiva
Mayo Clinic

La mayoría de los pacientes con enfermedad de Alzheimer (EA) y enfermedad de alzheimer y las demencias relacionadas (DRDA, por sus siglas en inglés) experimenta el inicio gradual y la progresión de los síntomas cognitivos, lo que los lleva al deterioro a lo largo de los años o décadas. Sin embargo, en un pequeño subconjunto de pacientes, los síntomas comienzan rápidamente, lo que lleva a la demencia dentro de un año y a la discapacidad total dentro de los dos años posteriores al inicio de los síntomas. Un nuevo estudio en Mayo Clinic tiene como objetivo determinar por qué los pacientes con la enfermedad de Alzheimer y DRDA desarrollan esta demencia rápidamente progresiva (DRP).

Released: 31-Mar-2025 8:00 AM EDT
Mayo Clinic Researchers Study Causes of Rapidly Progressive Dementia
Mayo Clinic

Most patients with Alzheimer's disease and Alzheimer's Disease Related Dementias (ADRD) experience the gradual onset and progression of cognitive symptoms, leading to decline over years or decades. However, in a small subset of patients, symptoms begin rapidly, leading to dementia within one year and complete incapacitation within two years of symptom onset.

鶹ý: Highly Accurate Blood Test Diagnoses Alzheimer’s Disease, Measures Extent of Dementia
Released: 31-Mar-2025 5:00 AM EDT
Highly Accurate Blood Test Diagnoses Alzheimer’s Disease, Measures Extent of Dementia
Washington University in St. Louis

A newly developed blood test for Alzheimer’s disease not only aids in the diagnosis of the neurodegenerative condition but also indicates how far it has progressed, according to a study by researchers at Washington University School of Medicine in St. Louis and Lund University in Sweden.

Released: 26-Mar-2025 8:05 PM EDT
Study Unlocks How Diabetes Distorts Memory and Reward Processing
University of Nevada, Las Vegas (UNLV)

Type 2 diabetes may rewire the brain in ways that mimic early Alzheimer’s disease — and UNLV researchers say the “why” may lie in a previously unexplored connection between high blood sugar levels and a key part of the brain called the anterior cingulate cortex (ACC).

Released: 26-Mar-2025 4:00 PM EDT
Early Signs of Heart Problems Linked to Smaller Brain Volumes
American Academy of Neurology (AAN)

MINNEAPOLIS — People who have early signs of heart problems may also have changes in brain health that can be early signs of dementia, such as loss of brain volume, according to a meta-analysis published on March 26, 2025, online in Neurology®, the medical journal of the American Academy of Neurology. The meta-analysis does not prove that early heart problems cause loss of brain cells; it only shows an association.

Released: 26-Mar-2025 4:00 PM EDT
Your Neighborhood May Affect Your Risk of Dementia
American Academy of Neurology (AAN)

People living in more disadvantaged neighborhoods may be more likely to develop dementia than people living in neighborhoods with fewer disadvantages, according to a study published on March 26, 2025, online in Neurology®, the medical journal of the American Academy of Neurology.

Released: 26-Mar-2025 11:00 AM EDT
Highly Educated People Face Steeper Mental Declines After Stroke
Michigan Medicine - University of Michigan

Stroke survivors who have attended some level of higher education may face even steeper mental declines, according to a study led by Michigan Medicine. The findings suggest that attending higher education may enable people to retain greater cognitive ability until a critical threshold of brain injury is reached after a stroke.

Released: 26-Mar-2025 9:35 AM EDT
Pioneering Tests Could Improve the Assessment of Dementia in Ageing Africans
University of the Witwatersrand, Johannesburg

Researchers have introduced specialised dementia tests tailored for older African adults, improving on standard cognitive assessments. These tools, part of HAALSI-HCAP, aim to address data gaps in Africa's ageing studies. The initiative aligns with global efforts and may inform national dementia surveys in South Africa.

鶹ý: How Cholesterol Regulation May Affect Alzheimer’s Development
Released: 26-Mar-2025 8:45 AM EDT
How Cholesterol Regulation May Affect Alzheimer’s Development
University of California, San Francisco (UCSF)

To determine the underlying causes of neuronal vulnerability at the earliest stages of Alzheimer's disease (AD), a research team from the UC San Francisco’s Memory & Aging Center made use of brain tissue samples from two brain regions with differing susceptibility to AD.

鶹ý: Neuroscientists Fine-Tune Zinc Activity to Improve Messaging in Brain
Released: 20-Mar-2025 6:30 PM EDT
Neuroscientists Fine-Tune Zinc Activity to Improve Messaging in Brain
West Virginia University

West Virginia University neuroscientists have discovered a way to control how much zinc is released to specific locations in the brain. The essential mineral plays a major role in the organ’s function, including improving memory and lessening symptoms of some neurological disorders, but getting the right amount to the right place is key.

鶹ý: Anti-Amyloid Drug Shows Signs of Preventing Alzheimer’s Dementia
Released: 19-Mar-2025 7:30 PM EDT
Anti-Amyloid Drug Shows Signs of Preventing Alzheimer’s Dementia
Washington University in St. Louis

An experimental drug appears to reduce the risk of Alzheimer’s-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a study led by the Knight Family Dominantly Inherited Alzheimer Network-Trials Unit (DIAN-TU), which is based at WashU Medicine.

Released: 19-Mar-2025 4:00 PM EDT
Sleepier During the Day? For Some Older People, It’s Linked to Twice the Dementia Risk
American Academy of Neurology (AAN)

For women in their 80s, experiencing increasing sleepiness during the day over a five-year period is associated with double the risk of developing dementia during that time, according to a study published on March 19, 2025, online in Neurology®, the medical journal of the American Academy of Neurology. The study does not prove that daytime sleepiness causes dementia; it only shows an association.

鶹ý: Stem Cell Trial for Early Alzheimer’s Disease Begins at UTHealth Houston
Released: 14-Mar-2025 10:15 AM EDT
Stem Cell Trial for Early Alzheimer’s Disease Begins at UTHealth Houston
University of Texas Health Science Center at Houston

A stem cell therapy trial aimed at reducing neuroinflammation in patients with presymptomatic Alzheimer’s disease is underway at UTHealth Houston.

鶹ý: COADance_01.png
Released: 13-Mar-2025 9:10 PM EDT
UWF Studies Positive Impacts of Dance for Individuals with Dementia
University of West Florida

A study by a team of University of West Florida researchers, conducted with Council on Aging of West Florida’s adult day care, The Retreat, uncovered insights into the positive impact of dance on individuals living with Alzheimer’s and related dementias.

鶹ý: Spotiphy Integrative Analysis Tool Turns Spatial RNA Sequencing Into Imager
Released: 12-Mar-2025 8:10 PM EDT
Spotiphy Integrative Analysis Tool Turns Spatial RNA Sequencing Into Imager
St. Jude Children's Research Hospital

Spatial transcriptomics is a cutting-edge technique that characterizes gene expression within sections of tissue, such as heart, skin or liver tissue. Scientists at St. Jude and the University of Wisconsin-Madison today share a generative algorithm for achieving both high genome and image resolution.

Released: 11-Mar-2025 7:25 PM EDT
AI-Driven Robotics Research Aims to Enhance Care for Older Adults with Alzheimer’s
Case Western Reserve University

Case Western Reserve University researchers are testing an AI-powered robot named Ruyi to support seniors with early-stage Alzheimer’s.

鶹ý: Enhancing Neural Signal Fidelity: Controlling Ultramicroelectrode Tip Exposure for Single-Cell Recording
Released: 11-Mar-2025 7:50 AM EDT
Enhancing Neural Signal Fidelity: Controlling Ultramicroelectrode Tip Exposure for Single-Cell Recording
Chinese Academy of Sciences

Long-term and precise intracellular signal detection is critical for advancing our understanding of brain diseases and developing effective diagnostic tools. A breakthrough method has been introduced to enhance the stability and fidelity of recording signals at the single-cell level using ultrafine electrodes (UME). By controlling the tip exposure of UMEs, researchers have demonstrated a significant improvement in their ability to resist environmental interference, thus improving signal-to-noise ratio and sensitivity, and the collection area has been precisely controlled. This method promises to enhance the performance of implantable neural interfaces for real-time monitoring of intracellular signals.



close
2.58554